Vetoquinol have traditionally been present in the companion animal dermatology market with prescription products for both otology and our antibiotic range. Dermatology is a key strategic domain for Vetoquinol and a key focus for future research and development.
In 2022 Vetoquinol UK launched Phovia, a unique innovation in dermatology, providing benefit to pets via fluorescent light energy. The Phovia system helps to create an environment supporting the skin’s own regeneration mechanisms. Phovia provides in-clinic, non-invasive light application, combining blue LED light and chromophore gel for photobiomodulation. Phovia empowers the whole practice clinical team to support their patient’s quality of life through stimulating the patient’s own healing process with new and innovative technology.